The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.50 (1.357%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 111.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Jan 2018 07:00

RNS Number : 1627B
McBride PLC
08 January 2018
 

8 January 2018

 

McBride plc

Trading Update

 

McBride plc, the leading European manufacturer and supplier of Co-manufactured and Private Label products for the Household and Personal Care market, provides its trading update for the six months ended 31 December 2017.

The Group starts its second half year with Household sales growth prospects significantly ahead of expectations but at the same time facing weak trading in the European Personal Care & Aerosols division ("PCA") and ongoing cost inflation in the near term. The combination of these factors means that the Board now expects full year earnings to be broadly in line with the prior year.

For the first half year, Group revenues at constant currency declined 0.6%. Excluding sales from Danlind, which was acquired at the end of September, underlying Household revenues were 3.4% lower versus the same period last year, with growth in the UK and South regions offset by ongoing decline in France and the negative impact in Germany of the previously-disclosed major contract loss. This reduction in revenues is now expected to be more than reversed during the second half year.

Trading at our European PCA division has been more challenging in the period and revenues declined 12.1%, approximately half of which was due to deliberate management actions to exit certain customer and product arrangements. As previously stated, we are currently developing an accelerated transformation plan for PCA and will provide more information in due course.

The lower sales levels and a number of mainly external cost challenges, including raw materials, labour market pressures and transportation costs, have impacted the Group's first half profit performance, particularly within PCA, such that adjusted operating profit for the first six months of the year will be lower than the Board's prior internal expectations. The revenue and profit performance of Danlind for its first three months as part of the Group have been in line with our expectations at the time of acquisition.

Looking ahead, the Group's growth prospects have been significantly enhanced by recent business wins, mainly arising from competitor weakness, with a number of major customers turning to the Group for support. We anticipate that these opportunities will lead to annualised high-single digit growth for the Household business. These additional sales are anticipated to phase in through the second half of the current financial year and Household is now expected to deliver mid-to-high single digit underlying revenue growth in the second half.

In order to capture this growth opportunity and support our customers, the Group has decided to defer certain efficiency and rationalisation initiatives planned for the current financial year, given the resources required in the near term to meet the anticipated rapid increase in volumes. The combination of the trading performance in the first half, ongoing cost inflation and the operational requirements of accommodating a significant level of new business means that the Group's full year adjusted profit before tax and adjusted EPS are now expected to be broadly in line with the prior year.

Although challenges remain in the European PCA business, we remain pleased with the sustained progress in our Household division, where our "Repair, Prepare, Grow" strategy is now delivering tangible benefits and the Board remains confident in the successful delivery of the Group's strategy.

Rik De Vos, Group Chief Executive, commented;

"Whilst the accelerated growth opportunity we are now seeing is an encouraging validation of the Group's strategy and the positioning of our Household business, the immediate task of accommodating such substantial growth presents challenges and choices.  Despite the near-term margin pressures we are experiencing, we remain focused on delivering our medium-term financial targets and we will re-initiate various efficiency projects once this growth has been absorbed. Additionally, restoring the performance of our PCA business, the plans for which are under consideration, remains a top priority." 

 

For further information please contact:

 

McBride plc

 

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

 

 

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZDLFBVFFEBBQ
Date   Source Headline
1st Sep 20208:13 amRNSHolding(s) in Company
19th Aug 20207:00 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSTrading update
26th Jun 20207:00 amRNSRedemption of B Shares
11th Jun 20207:00 amRNSDirectorate Change
19th May 20207:00 amRNSTrading Update
13th May 20204:35 pmRNSHolding(s) in Company
5th May 20205:00 pmRNSRedemption of B Shares
1st May 20207:00 amRNSChange in Remuneration Committee Responsibilities
28th Apr 20205:05 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSCOVID-19 Update
27th Feb 20205:00 pmRNSDirector/PDMR Shareholding
20th Feb 20207:00 amRNSHalf-year Report
16th Jan 20204:39 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSTrading Update
2nd Dec 20193:16 pmRNSIssue of B Shares as Part of the B Share Scheme
14th Nov 20197:00 amRNSDirectorate Change
6th Nov 20199:32 amRNSDirector/PDMR Shareholding
4th Nov 20194:00 pmRNSDirector/PDMR Shareholding
25th Oct 20193:57 pmRNSDirector/PDMR Shareholding
23rd Oct 20194:49 pmRNSResult of AGM
22nd Oct 20197:00 amRNSAGM Trading Update
15th Oct 20195:01 pmRNSTR1 Notification of major share holdings
8th Oct 20195:12 pmRNSDirector/PDMR Shareholding
8th Oct 20194:04 pmRNSDirector/PDMR Shareholding
8th Oct 20192:54 pmRNSDirector/PDMR Shareholding
7th Oct 20197:00 amRNSAppointment of Chairman Elect
4th Oct 20194:30 pmRNSDirector/PDMR Shareholding
4th Oct 20194:30 pmRNSHolding(s) in Company
4th Oct 20192:05 pmRNSAppointment of CEO and Chairman Succession
30th Sep 20194:12 pmRNSHolding(s) in Company
30th Sep 20194:05 pmRNSHolding(s) in Company
20th Sep 20194:00 pmRNSTotal Voting Rights
20th Sep 20194:00 pmRNSAnnual Report & Accounts & Notice of AGM
12th Sep 201911:06 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSFinal Results
17th Jul 20193:18 pmRNSHolding(s) in Company
16th Jul 20194:25 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSTrading Update
26th Jun 20197:00 amRNSDirectorate Change
3rd Jun 20194:30 pmRNSIssue of B Shares as Part of the B Share Scheme
3rd Jun 20197:00 amRNSDirectorate Change
2nd May 20197:00 amRNSDirectorate Change and Trading Update
5th Apr 20192:23 pmRNSDirector/PDMR Shareholding
25th Mar 20194:38 pmRNSDirector Declaration
22nd Feb 201910:14 amRNSHolding(s) in Company
21st Feb 20197:00 amRNSHalf-year Report
20th Feb 20197:00 amRNSTrading Update
10th Jan 20197:00 amRNSTrading Update
4th Dec 20183:26 pmRNSIssue of B Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.